Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Jul 2014

Trossaert M, Lienhart A, Nougier C, Fretigny M, Sigaud M, Meunier S, Fouassier M, Ternisien C, Negrier C, Dargaud Y

Abstract excerpt

Thirty per cent of patients with mild haemophilia A (MHA) present markedly different FVIII: C level when assayed by one-stage clotting and two-stage chromogenic assays. It is, therefore, a real clinical challenge to predict the individual bleeding risk of these patients. The aim of the present work was to study the relationship between the bleeding tendency of these patients with the results of a panel of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Coagulation
Share to Factor VIII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hemophilia A

Share to Hemophilia Treatment and Research

Share to Hemorrhage

Share to Phenotype

Share to Young Adult

Source

Identifiers

PMID: 24517184
DOI: 10.1111/hae.12381

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.PMID 24517184Read ↗

One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype.Semantic proximity Read ↗

Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.Semantic proximity Read ↗

Comparing one stage, chromogenic assay results and discrepancies with bleeding phenotype and genetic variants in females with hemophilia A.Semantic proximity Read ↗

Mild hemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype.Semantic proximity Read ↗

Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays.Semantic proximity Read ↗

Genetic analysis of non-severe hemophilia A phenotype with A discrepancy between one-stage and chromogenic factor VIII activity assays.Semantic proximity Read ↗

Discrepancy between one-stage and chromogenic factor VIII activity assay results can lead to misdiagnosis of haemophilia A phenotype.Semantic proximity Read ↗

Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B.Semantic proximity Read ↗

One-stage vs. chromogenic assays in haemophilia A.Semantic proximity Read ↗

Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.Semantic proximity Read ↗

In vitro kinetics of factor VIII activity in patients with mild haemophilia A and a discrepancy between one-stage and two-stage factor VIII assay results.Semantic proximity Read ↗

Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.